Dysregulation of Lrp-1 at the BBB has been shown to contribute to neurotoxic amyloid-β (Aβ) brain accumulation of Aβ in the brain, which drives the Alzheimer’s disease pathology. This evidence concerns the gene LRP1 and early-onset autosomal dominant Alzheimer disease.